Concepedia

M. Teresa Cibeira

MT

Statistics

Publications

12

Citations

1.7K

H-Index

10

Active since

2004

Affiliations

Hospital Clínic de Barcelona(Current)

Consorci Institut D'Investigacions Biomediques August Pi I Sunyer

Universitat de Barcelona

Leitat Technological Center

Complejo Hospitalario de Salamanca

M. Teresa Cibeira is an author at Hospital Clínic de Barcelona specializing in medicine, hematology, and multiple myeloma.

Publications per year

2004–2022

12

Publications

12

Daratumumab-Based Treatment for Immunoglobulin Light-Chain Amyloidosis

Efstathios Kastritis, Giovanni Palladini, Monique C. Minnema et al. · New England Journal of Medicine · 2021 · 668 citations · Full text

Life Sciences, Hematology, Pharmacology +15

Superiority of bortezomib, thalidomide, and dexamethasone (VTD) as induction pretransplantation therapy in multiple myeloma: a randomized phase 3 PETHEMA/GEM study

Laura Rosiñol, Albert Oriol, Ana Isabel Teruel et al. · Blood · 2012 · 485 citations · Full text

Medicine, Hematology, Pharmacology +14

Extramedullary multiple myeloma escapes the effect of thalidomide.

Laura Rosiñol, M. Teresa Cibeira, Joan Bladé et al. · PubMed · 2004 · 135 citations

Medicine, Hematology, Pharmacotherapy +17

Bortezomib: an effective agent in extramedullary disease in multiple myeloma

Laura Rosiñol, M. Teresa Cibeira, Carla Uriburu et al. · European Journal Of Haematology · 2006 · 127 citations

Medicine, Hematology, Pharmacology +16

Evolving M-protein pattern in patients with smoldering multiple myeloma: impact on early progression

Carlos Fernández de Larrea, Ignacio Isola, Arturo Pereira et al. · Leukemia · 2018 · 65 citations

Medicine, Hematology, Oncology +14

1–5 of 12